PRAMIPEXOLE GxP pramipexole dihydrochloride 0.25 mg tablets blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg

Tilgjengelig fra:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

pramipexole dihydrochloride monohydrate

Legemiddelform:

Tablet, uncoated

Sammensetning:

Excipient Ingredients: mannitol; pregelatinised maize starch; magnesium stearate; povidone; silicon dioxide

Administreringsrute:

Oral

Enheter i pakken:

10, 30, 100

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

Produkt oppsummering:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorisasjon status:

Licence status A

Autorisasjon dato:

2014-09-23